Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis

OBJECTIVE: To investigate the efficacy and safety of belimumab, a fully human immunoglobulin G1λ monoclonal antibody against B-lymphocyte stimulator, in participants with generalized myasthenia gravis (MG) who remained symptomatic despite standard of care (SoC) therapy. METHODS: Eligible participant...

Descripción completa

Detalles Bibliográficos
Autores principales: Hewett, Karen, Sanders, Donald B., Grove, Richard A., Broderick, Christine L., Rudo, Todd J., Bassiri, Ashlyn, Zvartau-Hind, Marina, Bril, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902787/
https://www.ncbi.nlm.nih.gov/pubmed/29661905
http://dx.doi.org/10.1212/WNL.0000000000005323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902787/
https://www.ncbi.nlm.nih.gov/pubmed/29661905
http://dx.doi.org/10.1212/WNL.0000000000005323

Ejemplares similares